Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1997 1
1999 2
2001 4
2002 2
2003 2
2004 2
2005 3
2006 4
2007 3
2008 3
2009 1
2010 3
2012 4
2016 1
2017 2
2018 2
2019 2
2020 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Reduced plasminogen activator inhibitor 1 antigen"
Page 1
Measuring Fibrinolysis.
Longstaff C. Longstaff C. Hamostaseologie. 2021 Feb;41(1):69-75. doi: 10.1055/a-1325-0268. Epub 2021 Feb 15. Hamostaseologie. 2021. PMID: 33588458
Fibrinolysis can be accelerated by preparing euglobulin from plasma to reduce endogenous inhibitors, or by adding plasminogen activators to normal plasma. However, these manipulations complicate interpretation of results and diagnosis of a "fibrinolysis deficit." Many obse …
Fibrinolysis can be accelerated by preparing euglobulin from plasma to reduce endogenous inhibitors, or by adding plasminogen activat …
Plasminogen activator inhibitor type 1 deficiency.
Mehta R, Shapiro AD. Mehta R, et al. Haemophilia. 2008 Nov;14(6):1255-60. doi: 10.1111/j.1365-2516.2008.01834.x. Haemophilia. 2008. PMID: 19141166 Review.
Plasminogen activator inhibitor type 1 (PAI-1) is an important component of the coagulation system that down-regulates fibrinolysis in the circulation. Reduced PAI-1 levels may result in increased fibrinolysis and an associated bleeding diathesis. ...Reported normal ranges …
Plasminogen activator inhibitor type 1 (PAI-1) is an important component of the coagulation system that down-regulates fibrinolysis in the c …
Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass.
Pretorius M, Donahue BS, Yu C, Greelish JP, Roden DM, Brown NJ. Pretorius M, et al. Circulation. 2007 Sep 11;116(11 Suppl):I1-7. doi: 10.1161/CIRCULATIONAHA.106.677906. Circulation. 2007. PMID: 17846288
Patients who developed postoperative AF (67 subjects, 26.5%) were significantly older (P<0.001), more likely to have a remote history of AF (P<0.001), and tended to be more likely to have had valve surgery (P=0.082). Plasminogen activator inhibitor-1
Patients who developed postoperative AF (67 subjects, 26.5%) were significantly older (P<0.001), more likely to have a remote history of …
Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome.
Wang L, Rockwood J, Zak D, Devaraj S, Jialal I. Wang L, et al. Metab Syndr Relat Disord. 2008 Jun;6(2):149-52. doi: 10.1089/met.2008.0012. Metab Syndr Relat Disord. 2008. PMID: 18484901 Free PMC article. Clinical Trial.
We previously showed that simvastatin has concomitant benefits in reducing low-density lipoprotein (LDL)-cholesterol and inflammation in MS subjects. The levels of plasminogen activator inhibitor 1(PAI-1), soluble P-selectin (sP-selectin), and s …
We previously showed that simvastatin has concomitant benefits in reducing low-density lipoprotein (LDL)-cholesterol and inflammation …
Neisseria meningitidis lipopolysaccharides in human pathology.
Brandtzaeg P, Bjerre A, Øvstebø R, Brusletto B, Joø GB, Kierulf P. Brandtzaeg P, et al. J Endotoxin Res. 2001;7(6):401-20. J Endotoxin Res. 2001. PMID: 11753210 Review.
Hemorrhagic skin lesions and thrombosis are caused by up-regulation of tissue factor which induces coagulation, and by inhibition of fibrinolysis by plasminogen activator inhibitor 1 (PAI-1). Effective antibiotic treatment results in a rapid decline of …
Hemorrhagic skin lesions and thrombosis are caused by up-regulation of tissue factor which induces coagulation, and by inhibition of fibrino …
Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and SERPINE1 Expression in CaSki Cells.
Palafox-Mariscal LA, Ortiz-Lazareno PC, Jave-Suárez LF, Aguilar-Lemarroy A, Villaseñor-García MM, Cruz-Lozano JR, González-Martínez KL, Méndez-Clemente AS, Bravo-Cuellar A, Hernández-Flores G. Palafox-Mariscal LA, et al. Int J Mol Sci. 2023 Jun 24;24(13):10592. doi: 10.3390/ijms241310592. Int J Mol Sci. 2023. PMID: 37445768 Free PMC article.
PTX pretreatment prior to the addition of TNF-alpha and TGF-beta1 significantly reduced N-cadherin and Vimentin levels. To our knowledge, this is the first time that this effect of PTX has been reported. Additionally, PTX reduced the phosphorylation of IkappaB-alpha …
PTX pretreatment prior to the addition of TNF-alpha and TGF-beta1 significantly reduced N-cadherin and Vimentin levels. To our knowle …
Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
Schoergenhofer C, Matzneller P, Mußbacher M, Schmid JA, Jilma-Stohlawetz P, Zeitlinger M, Jilma B. Schoergenhofer C, et al. Thromb Haemost. 2017 Aug 30;117(9):1714-1721. doi: 10.1160/TH17-03-0196. Epub 2017 Aug 10. Thromb Haemost. 2017. PMID: 28796276 Free PMC article. Clinical Trial.
Plasma levels of F1+2 prothrombin fragments, thrombin-antithrombin complexes (TAT), von Willebrand factor antigen levels (vWF), E-selectin, plasmin-antiplasmin complexes (PAP), tissue-type plasminogen activator (t-PA) antigen and activity, plasminogen acti
Plasma levels of F1+2 prothrombin fragments, thrombin-antithrombin complexes (TAT), von Willebrand factor antigen levels (vWF), E-sel …
Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.
Ekholm M, Jekell A, Wallén NH, Gigante B, Kahan T. Ekholm M, et al. J Cardiovasc Pharmacol. 2018 Apr;71(4):240-247. doi: 10.1097/FJC.0000000000000565. J Cardiovasc Pharmacol. 2018. PMID: 29389738 Clinical Trial.
Inflammatory markers (interleukin-6, soluble interleukin-6 receptor, interleukin-8, tumor necrosis factor-alpha, monocyte chemoattractant protein-1, and C-reactive protein) and hemostasis (plasminogen activator inhibitor-1 activity, tissue plasminogen …
Inflammatory markers (interleukin-6, soluble interleukin-6 receptor, interleukin-8, tumor necrosis factor-alpha, monocyte chemoattractant pr …
A novel ELISA for the detection of active form of plasminogen activator inhibitor-1 based on a highly specific trapping agent.
Shang L, Xue G, Gong L, Zhang Y, Peng S, Yuan C, Huang M. Shang L, et al. Anal Chim Acta. 2019 Apr 11;1053:98-104. doi: 10.1016/j.aca.2018.12.005. Epub 2018 Dec 12. Anal Chim Acta. 2019. PMID: 30712574
Plasminogen activator inhibitor-1 (PAI-1) is a labile molecule that exists in four different forms: active, latent, cleaved and target bound form. ...We used this strategy to measure the active PAI-1 level in plasma of healthy donors, and had an intere
Plasminogen activator inhibitor-1 (PAI-1) is a labile molecule that exists in four different forms: active, late
Coagulation and fibrinolysis in preeclampsia and neonates.
Tanjung MT, Siddik HD, Hariman H, Koh SC. Tanjung MT, et al. Clin Appl Thromb Hemost. 2005 Oct;11(4):467-73. doi: 10.1177/107602960501100415. Clin Appl Thromb Hemost. 2005. PMID: 16244774 Free article.
Preeclamptic women in labor showed further enhanced coagulation activation (F(1+2)) with raised urokinase-like plasminogen activator (u-PA) activity and reduced plasminogen activator inhibitor-2 (PAI-2) levels. In preterm preeclampsia, significantly reduced antithro …
Preeclamptic women in labor showed further enhanced coagulation activation (F(1+2)) with raised urokinase-like plasminogen activator (u-PA) …
46 results